Skip Navigation



European Heart Journal Advance Access published online on November 16, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi653
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
27/1/10    most recent
ehi653v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rauchhaus, M.
Right arrow Articles by Anker, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rauchhaus, M.
Right arrow Articles by Anker, S. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Heart Journal © The European Society of Cardiology 2005; all rights reserved

Editorial

Heart failure therapy: testosterone replacement and its implications

Mathias Rauchhaus 1 *, Wolfram Doehner 1, and Stefan D. Anker 2

1 Abteilung für Angewandte Kachexieforschung, Medizinische Klinik mit Schwerpunkt für Kardiologie, Campus Virchow-Klinikum (CVK), Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany
2 Abteilung für Angewandte Kachexieforschung, Medizinische Klinik mit Schwerpunkt für Kardiologie, Campus Virchow-Klinikum (CVK), Charité, Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany; Clinical Cardiology, National Heart and Lung Institute, London, UK

* To whom correspondence should be addressed.
Mathias Rauchhaus, E-mail: mathias.rauchhaus{at}charite.de



This article has no Abstract.

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
P. Aukrust, T. Ueland, L. Gullestad, and A. Yndestad
Testosterone: a novel therapeutic approach in chronic heart failure?
J. Am. Coll. Cardiol., September 1, 2009; 54(10): 928 - 929.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Bell, E. R. Porrello, C. E. Huggins, S. B. Harrap, and L. M. D. Delbridge
The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1514 - H1522.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.